(Q39062382)

8 September 2017

The tumor suppressor, TAX1BP2, is a novel substrate of ATM kinase (English)

1 reference

8 September 2017

W L Lai

1

1 reference

8 September 2017

W Y Hung

series ordinal

2

1 reference

8 September 2017

Y P Ching

series ordinal

3

1 reference

8 September 2017

language of work or name

English

0 references

publication date

18 November 2013

1 reference

8 September 2017

1 reference

8 September 2017

33

1 reference

8 September 2017

45

1 reference

8 September 2017

5303-5309

1 reference

https://scigraph.springernature.com/pub.10.1038/onc.2013.481

8 September 2017

0 references

cites work

Targeted therapy of hepatocellular cancer.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.481

Are there opportunities for chemotherapy in the treatment of hepatocellular cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.481

The centrosome cycle: Centriole biogenesis, duplication and inherent asymmetries

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.481

The retroviral oncoprotein Tax targets the coiled-coil centrosomal protein TAX1BP2 to induce centrosome overduplication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.481

The centrosomal protein Tax1 binding protein 2 is a novel tumor suppressor in hepatocellular carcinoma regulated by cyclin-dependent kinase 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.481

DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.481

The complexity of p53 stabilization and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.481

Centrosomal localization of DNA damage checkpoint proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.481

Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.481

ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.481

Activation of the ATM kinase by ionizing radiation and phosphorylation of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.481

Requirement of ATM in phosphorylation of the human p53 protein at serine 15 following DNA double-strand breaks

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.481

What Determines the Specificity and Outcomes of Ubiquitin Signaling?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.481

Induction of p53 renders ATM-deficient mice refractory to hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.481

P21-activated protein kinase is overexpressed in hepatocellular carcinoma and enhances cancer metastasis involving c-Jun NH2-terminal kinase activation and paxillin phosphorylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.481

Substrate specificities and identification of putative substrates of ATM kinase family members

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.481

21 January 2018

Identifiers

DOI

10.1038/ONC.2013.481

1 reference

release_okcoikjesrgrvobwxelnopwjia

8 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/okcoikjesrgrvobwxelnopwjia

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference